Ionis reports positive Phase 3 interim results for sefaxersen in IgA nephropathy

Ionis reported positive prespecified interim Phase 3 results for sefaxersen showing significant proteinuria reduction versus placebo at 37 weeks.Key Highlights:Original SEC Filing: IONIS PHARMACEUTICALS INC [ IONS ] - 8-K - Sep. 23, 2026This is an AI-powered summary. It may contain inaccuracies. Co…